We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comment on "Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis".
- Authors
Nevez, Gilles; Hoffmann, Claire; Le Gal, Solène
- Abstract
The HIV infection was correctly controlled by highly active antiretroviral therapy (HAART), but the patient developed PCP after corticosteroid treatment (prednisone, 40 mg/day, 24 days) for hypersensitivity pneumonitis. REFERENCES 1 Sullivan A., Lanham T., Krol R., Zachariah S. Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/ L and Atovaquone Prophylaxis. We read with interest the article by Sullivan and colleagues [[1]], who described a case of I Pneumocystis i pneumonia (PCP) occurrence in a HIV-infected patient without severe defect of CD4 SP + sp T-cell count in blood and despite PCP prophylaxis by atovaquone.
- Subjects
PNEUMOCYSTIS pneumonia; PNEUMOCYSTIS jiroveci; CD4 lymphocyte count; AIDS; HIV-positive persons; HIGHLY active antiretroviral therapy
- Publication
Case Reports in Infectious Diseases, 2023, p1
- ISSN
2090-6625
- Publication type
Case Study
- DOI
10.1155/2023/9793264